NCT00043303View on ClinicalTrials.gov

Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis

PHASE2CompletedINTERVENTIONAL
Enrollment

502

Participants

Timeline

Start Date

September 30, 2001

Study Completion Date

November 30, 2003

Conditions
Liver FibrosisCirrhosis
Interventions
DRUG

interferon gamma-1b

100 or 200 mcg, SQ, 3x per week

Sponsors

Lead Sponsor

InterMune
All Listed Sponsors
lead

InterMune

INDUSTRY

NCT00043303 - Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis | Biotech Hunter | Biotech Hunter